Antiproliferative activity of new 2-glyco-3-nitro-1,2-dihydroquinolines and quinolines synthesized under solventless conditions promoted by neutral alumina

2018 ◽  
Vol 42 (22) ◽  
pp. 18342-18347 ◽  
Author(s):  
V. Luque-Agudo ◽  
José M. Padrón ◽  
E. Román ◽  
J. A. Serrano ◽  
M. V. Gil

This paper describes the syntheses of new 2-glyco-3-nitro-1,2-dihydroquinolines and 2-glyco-3-nitroquinolines by one-pot aza-Michael–Henry-dehydration reactions using green procedures, as well as the evaluation of their antiproliferative activity.


2020 ◽  
Vol 17 (12) ◽  
pp. 951-958
Author(s):  
Pallava Nagaraju ◽  
Pedavenkatagari Narayana Reddy ◽  
Pannala Padmaja ◽  
Vinod G. Ugale

A new class of 4H,5H-benzo[4,5]thiazolo[3,2-a]pyrano[2,3-d]pyrimidin-5-one and 5H,6Hpyrano[ 2,3-d]thiazolo[3,2-a]pyrimidin-5-one derivatives were synthesized via the one-pot threecomponent reaction of 2-hydroxy-4H-benzo[4,5]thiazolo[3,2-a]pyrimidin-4-one and 7-hydroxy-5Hthiazolo[ 3,2-a]pyrimidin-5-one to various aromatic aldehydes and malononitrile. This domino transformation involves the formation of pyranopyrimidine ring by the formation of three C–C bonds and one C– O bond a single synthetic operation. As the products precipitate out of the reaction, simple filtration is enough to gather the products, and thus, there is no need for work-up or column-chromatography. The synthesized thiazole/benzothiazole fused pyranopyrimidine derivatives were evaluated for their antiproliferative activity against four cancer cell lines namely DU 145 (prostate cancer), Hela (Human cervical cancer), MDA-MB-231 (breast cancer), HT-29 (Human colon cancer) and normal cell line HEK293 (human embryonic kidney cells). The results demonstrated that synthesized compounds were selective in its cytotoxicity to cancer cells compared to normal cells. Among these compounds, 2-amino-9- methoxy-5-oxo-4-(3,4,5-trimethoxyphenyl)-4H,5H-benzo[4,5]thiazolo[3,2-a]pyrano[2,3-d]pyrimidine- 3-carbonitrile 4i exhibited the most potent antiproliferative activity against the tested cell lines. Molecular docking studies revealed that these active heterocyclic molecules bind selectively in the colchicine binding site of tubulin polymer.



2012 ◽  
Vol 22 (1) ◽  
pp. 88-93 ◽  
Author(s):  
Prakash T. Parvatkar ◽  
Amrendra Kumar Ajay ◽  
Manoj Kumar Bhat ◽  
Perunninakulath S. Parameswaran ◽  
Santosh G. Tilve


2021 ◽  
Vol 17 ◽  
pp. 2026-2027
Author(s):  
Giovanna Bosica ◽  
Kaylie Demanuele ◽  
José Manuel Padrón ◽  
Adrián Puerta


ChemInform ◽  
2014 ◽  
Vol 45 (44) ◽  
pp. no-no
Author(s):  
S. Elavarasan ◽  
D. Bhakiaraj ◽  
B. Chellakili ◽  
T. Elavarasan ◽  
M. Gopalakrishnan


2011 ◽  
Vol 172 (1) ◽  
pp. 171-176 ◽  
Author(s):  
Nicolás M. Bertero ◽  
Carlos R. Apesteguía ◽  
Alberto J. Marchi


2010 ◽  
Vol 39 (8) ◽  
pp. 838-840 ◽  
Author(s):  
Atsushi Takagaki ◽  
Mika Ohara ◽  
Shun Nishimura ◽  
Kohki Ebitani


Molekul ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. 18
Author(s):  
Noval Herfindo ◽  
Riska Prasetiawati ◽  
Daniel Sialagan ◽  
Neni Frimayanti ◽  
Adel Zamri

This research has been successfully synthesized three compounds of 1,3,5-triaryl pyrazole derivatives by two steps reaction. Firstly, pyrazoline (4a-c) compound was obtained by one-pot reaction of aromatic ketones, aldehyde and hydrazine in basic condition. Then, pyrazole (5a-c) compound was obtained by oxidative aromatization of compound 4 in the presense of acetic acid. Chemical structure of predicted molecules was confirmed by FTIR, NMR and HRMS spectroscopy data analysis. Antiproliferative activity of compound 5a-c were evaluated by in vitro assay against MCF-7 cells line and molecular docking simulation against ERα (PDB ID: 3ERT) using MOE 2019. Biological evaluation result showed that pyrazole compounds had weak antiproliferative activity against MCF-7 cells with IC50 were > 1000 µM, whereas the docking studies agrees the result.



2014 ◽  
Vol 11 (4) ◽  
pp. 237-243 ◽  
Author(s):  
S. Elavarasan ◽  
D. Bhakiaraj ◽  
B. Chellakili ◽  
T. Elavarasan ◽  
M. Gopalakrishnan


2019 ◽  
Vol 16 (8) ◽  
pp. 846-860
Author(s):  
Mohana Rao Katiki ◽  
Dileep Kommula ◽  
Sowjanya Polepalli ◽  
Nishant Jain ◽  
Madugula Sree Rama Murty

Background: In an effort to establish new drug candidates with improved antiproliferative activity, we report here a novel class of compounds designed rationally by the replacement of an ethyl group in tamoxifen with a methylene (1H-1,2,4-triazole) and the introduction of 1,4- substituted 1,2,3-triazoles in the basic side chain. Methods: Magnetically separable iron oxide nanoparticles have been found to effectively catalyze the one-pot multicomponent click synthesis of 1,4-disubstituted 1,2,3-triazole conjugates in water. IR, 1HNMR, 13CNMR and HRMS experiments have been implemented for the unmistakable determination of the regiochemistry of the process. The novel compounds were evaluated for their antiproliferative activity against four human tumor cell lines, namely, MCF-7, MDA-MB-231, HeLa, and A549. Cell growth inhibition was assessed according to the standard Sulforhodamine B (SRB) cell proliferation method. Results: The most active compounds 4h, 4n and 5a have been identified with superior GI50 values in the range of 0.13–0.31 µM as compared with the reference drug, tamoxifen (0.25-0.72 µM). Conclusion: Additionally, taking the stereochemistry into consideration, E isomers seem slightly more active towards the tested cancer cell lines with respect to Z isomers.



Sign in / Sign up

Export Citation Format

Share Document